Description / Scope of the Technical Need.
We are seeking breakthrough and differentiated dosage forms and delivery formats, either launch-ready or at an advanced stage of development, with a clear path to industrial scale-up, across two focus areas:
1. Innovative OTC dosage forms and delivery formats:
Novel formats, next-generation evolutions of established formats, and existing formats not currently represented in our portfolio or target markets for the relevant API, incorporating at least one API relevant to our current portfolio across Allergy Relief, Cough & Cold, Digestive Wellness, Liver Care, Pain Management, and Physical & Mental Wellness.
2. Innovative formats for food supplements and medical devices:
Differentiated formats offering a superior sensory and consumer experience versus conventional options, including next-generation evolutions of existing formats such as gummies, softgels, tablets and other established dosage forms, as well as entirely new format concepts.
Across both areas, solutions should deliver clear added value through greater convenience, improved adherence, reduced dosing burden/posology, enhanced performance, and/or improved sustainability.
Our ambition is to enable differentiated, premium and scalable products across relevant routes of administration and delivery formats, including oral, nasal, topical and ophthalmic applications, where applicable.
Background.
At Opella, we are committed to empowering consumers to take greater control of their health. Breakthrough dosage forms and delivery formats can transform the self-care experience by making products more accessible, convenient, enjoyable, effective, and easier to use, while supporting better adherence and differentiated, premium propositions.
As consumer expectations continue to evolve, innovation in format, delivery, sensory experience, performance, and sustainability offers new opportunities to create self-care solutions that stand out from conventional products and better meet consumers’ needs.
Key Success Criteria.
Must-have Requirements.
- Relevant to OTC medicines, medical devices, and/or food supplements, with clear and meaningful added value versus conventional or existing market formats.
- Relevant to Opella’s current portfolio, health categories, and consumer needs.
- Launch-ready or at an advanced stage of development, with demonstrated manufacturing feasibility and scalability.
- Clear potential to deliver a differentiated and premium consumer proposition.
Preferred Requirements.
- Patented, patent-pending, or proprietary technology with a strong and defensible competitive advantage.
- First-to-market solution, with limited equivalent offerings currently available.
- Demonstrated potential to support a premium positioning and strong consumer appeal.
Approaches not of interest.
- Early-stage concepts lacking proven stability, efficacy, and a credible path to industrial scale-up and manufacturing.
- Me-too formats offering limited differentiation or added value versus existing market solution e.g. Food supplement gummies
- Solutions with no clear relevance to Opella’s portfolio or target health categories.
Target Group.
Adults and children, no specific health conditions
Geographies.
Global
Have a question or simply want to know more?
Any question or adverse reaction related to our products must be addressed via www.sanofi.com.
